OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could spare cancer patients harsh radiation
Disease control Recruiting nowThis study is testing if a simple blood test can help doctors personalize radiation treatment for people with HPV-related throat cancer. The goal is to give patients just enough treatment to control their cancer while reducing harsh side effects. Researchers will assign patients …
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Could throat cancer signal hidden health risks for partners?
Knowledge-focused Recruiting nowThis study aims to understand if women diagnosed with HPV-positive throat cancer, or the female partners of these patients, have a higher chance of also having high-risk HPV infections or related conditions in the genital area. It will observe 154 participants, who will complete …
Matched conditions: OROPHARYNGEAL HUMAN PAPILLOMAVIRUS-POSITIVE SQUAMOUS CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC